{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T14:10:30Z","timestamp":1740233430319,"version":"3.37.3"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jsbmb.2025.106697","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:47:11Z","timestamp":1738889231000},"page":"106697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Supportive effect of corticosteroid on bone marrow recovery in FLT3\/ITD positive acute myeloid leukemia with trisomy 13"],"prefix":"10.1016","volume":"248","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5166-5999","authenticated-orcid":false,"given":"Rie","family":"Tabata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiharu","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2025.106697_bib1","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)","volume":"100","author":"Byrd","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jsbmb.2025.106697_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cancergencyto.2004.03.008","article-title":"Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization","volume":"155","author":"Klaus","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.jsbmb.2025.106697_bib3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood-2007-02-072595","article-title":"Trisomy 13 is strongly associated with AML1\/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia","volume":"110","author":"Dicker","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jsbmb.2025.106697_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41375-018-0357-9","article-title":"Targeting FLT3 mutations in AML: Review of current knowledge and evidence","volume":"33","author":"Daver","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jsbmb.2025.106697_bib5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1200\/JCO.22.00715","article-title":"Prognostic value of FLT3-internal tandem duplication residual disease in acute Myeloid Leukemia","volume":"41","author":"Grob","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2025.106697_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106462","article-title":"Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia","volume":"99","author":"Bellis","year":"2020","journal-title":"Leuk. Res."},{"key":"10.1016\/j.jsbmb.2025.106697_bib7","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1182\/blood.2019001238","article-title":"Terminal deoxynucleotidyl transferase promotes acute myeloid leukemia by priming FLT3-ITD replication slippage","volume":"134","author":"Borrow","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jsbmb.2025.106697_bib8","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1182\/blood.2019001240","article-title":"Molecular roulette: nucleophosmin mutations in AML are orchestrated through N-nucleotide addition by TdT","volume":"134","author":"Borrow","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jsbmb.2025.106697_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jsbmb.2025.106697_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41408-023-00911-w","article-title":"Treatment of older adults with FLT3-mutated AML: emerging paradigms and the role of frontline FLT3 inhibitors","volume":"13","author":"Short","year":"2023","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.jsbmb.2025.106697_bib11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ajh.24140","article-title":"Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade","volume":"90","author":"Badar","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jsbmb.2025.106697_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.leukres.2005.05.015","article-title":"The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis","volume":"30","author":"Hicsonmez","year":"2006","journal-title":"Leuk. Res"},{"key":"10.1016\/j.jsbmb.2025.106697_bib13","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3324\/haematol.2017.184267","article-title":"Dexamethasone in hyperleukocytic acute myeloid leukemia","volume":"103","author":"Bertoli","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jsbmb.2025.106697_bib14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41408-017-0011-1","article-title":"Improved outcome for AML patients over the years 2000-2014","volume":"7","author":"Bertoli","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.jsbmb.2025.106697_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/modpathol.2012.142","article-title":"TdT expression in acute myeloid leukemia with minimal differentiation is associated with distinctive clinicopathological features and better overall survival following stem cell transplantation","volume":"26","author":"Patel","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jsbmb.2025.106697_bib16","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1158\/1078-0432.CCR-17-1259","article-title":"Chemogenomic landscape of RUNX1-mutated AML reveals importance of RUNX1 allele dosage in genetics and glucocorticoid sensitivity","volume":"23","author":"Simon","year":"2017","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.jsbmb.2025.106697_bib17","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/leu.2016.314","article-title":"Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML","volume":"31","author":"Malani","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jsbmb.2025.106697_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/srep36199","article-title":"Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML","volume":"6","author":"Kurata","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jsbmb.2025.106697_bib19","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/pbc.26011","article-title":"Glucocorticoid-induced proliferation in untreated pediatric acute myeloid leukemic blasts","volume":"63","author":"Klein","year":"2016","journal-title":"Pedia Blood Cancer"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076025000251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076025000251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T13:36:51Z","timestamp":1740231411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076025000251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":19,"alternative-id":["S0960076025000251"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106697","relation":{},"ISSN":["0960-0760"],"issn-type":[{"type":"print","value":"0960-0760"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supportive effect of corticosteroid on bone marrow recovery in FLT3\/ITD positive acute myeloid leukemia with trisomy 13","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106697"}}